CELLTOP 50 mg, soft capsule 20 capsules
Active ingredients: Etoposide
Commercialized according to BDPMDispensing in France: Prescription only
Soft capsule20 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CELLTOP 50 mg, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 20 capsule(s)
- Marketing authorisation holder
- BAXTER
- Reimbursement according to BDPM
- 100%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Lymphomes ("cancer du système lymphatique")<br>- Cancer des testicules<br>- Cancer des poumons (dits "à petites cellules")<br>- Leucémie myélocytaire (cancer se manifestant généralement par un trop grand nombre de globules blancs dans le sang) ; JOURNAL OFFICIEL ; 19/06/07
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jun 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67802057CIP73657580CIP133400936575806Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTOPOSIDEcapsule | 50 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.